GLP2 TZ 30MG
GLP2 TZ (Tirz) | 30mg | Dual GIP/GLP-1 Receptor Agonist Peptide
For In Vitro Research Use Only — Not for Human or Veterinary Use
Description:
GLP2 TZ is a synthetic dual agonist peptide targeting both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is widely used in in vitro metabolic research to explore mechanisms related to insulin secretion, appetite regulation, and energy balance. Studies suggest GLP2 TZ may influence adipose metabolism, glucose homeostasis, and weight-modulating pathways through synergistic receptor activation. Provided in a 30mg lyophilized format, GLP2 TZ is suited for advanced laboratory environments investigating metabolic, endocrine, and obesity-related research models
Specifications:
- Unit Size: 30mg (lyophilized powder, single vial)
- Molecular Weight: ~4813 Da
- Form: Crystalline lyophilized peptide
- Storage: Store dry at 2°C–8°C. After reconstitution, refrigerate between 2°C–8°C
Application Context:
GLP2 TZ is studied for its potential roles in:
-
Dual GIP/GLP-1 receptor signaling and appetite regulation
-
Enhancement of insulin secretion and glycemic control
-
Metabolic rate modulation and adipose utilization
-
In vitro obesity, metabolic syndrome, and fatty-liver model research
Intended Use:
This compound is intended strictly for qualified laboratory researchers. It is not for human or veterinary consumption and must not be used as a drug, food additive, cosmetic, or household product. It is supplied exclusively for controlled in vitro research applications.